SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group

SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.<br> 2023-03-27 Statistics Canada infostats@statcan.gc.ca Health and SafetySociety and Culturecoronaviruscoronavirus diseasediseases and physical health conditionshealthother content related to diseases and physical health conditionssociety and communitytable DatasetCSV https://www150.statcan.gc.ca/n1/tbl/csv/13100866-fra.zip DatasetCSV https://www150.statcan.gc.ca/n1/tbl/csv/13100866-eng.zip DatasetXML https://www150.statcan.gc.ca/n1/tbl/sdmx/13100866-SDMX.zip Supporting DocumentHTML https://www150.statcan.gc.ca/t1/tbl1/fr/tv.action?pid=1310086601 Supporting DocumentHTML https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310086601

Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.

Data and Resources

Similar records